Alkermes, Inc.
-
Ticker
ALKS
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1001-5000 Employees
- Based in Dublin, Ireland
Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders.
REPORT RATINGS
4.8 / 5.0 (320)
Alkermes, Inc. reports have an aggregate usefulness score of 4.8 based on 320 reviews.
Alkermes, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports